A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

PURPOSE: To study the therapeutic effects of probiotic Escherichia coli Nissle 1917 (EcN) in irritable bowel syndrome (IBS) and identify subgroups benefiting most. BACKGROUND: Some trials investigating therapeutic effects in irritable bowel syndrome have shown benefits in IBS subgroups only. Probiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruis, Wolfgang, Chrubasik, Sigrun, Boehm, Stephan, Stange, Christiane, Schulze, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307993/
https://www.ncbi.nlm.nih.gov/pubmed/22130826
http://dx.doi.org/10.1007/s00384-011-1363-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307993/
https://www.ncbi.nlm.nih.gov/pubmed/22130826
http://dx.doi.org/10.1007/s00384-011-1363-9

Ejemplares similares